Ningetinib (CT053PTSA) Plus Gefitinib in Stage IIIB or IV NSCLC Patients With EGFR Mutation and T790M Negative
Clinical trial NCT03758287 · COMPLETED
Trial details
- NCT number
- NCT03758287
- Sponsor
- Sunshine Lake Pharma Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-11-01
- Primary completion
- 2021-09-17
- Enrollment
- 108
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.